# AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/AIRS/airsculpt-technologies-announces-participation-in-upcoming-investor-conferences-2cfd961d
Ticker: AIRS
Company: Airsculpt Technologies
Source: Airsculpt Technologies
Published: 2026-05-27 20:05 EST
## Summary

AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and...

## Article Body
AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.

On June 3, 2026, the Company will participate in the TD Cowen 10th Annual Future of the Consumer Conference being held at the Lotte New York Palace in New York City. Management will host a fireside chat presentation at 11:45 a.m. Eastern Time and hold investor meetings throughout the day.

On June 9, 2026, the Company will participate in the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference being held virtually. Management will host a fireside chat presentation at 1:30 p.m. Eastern Time and hold virtual investor meetings throughout the day.

The fireside chat presentations at both conferences will be available live and for replay on the Investor Relations page on the company's website at https://investors.elitebodysculpture.com .

About AirSculpt

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

Investor Contact:

Allison Malkin Partner, ICR Inc. AirSculpt@icrinc.com
## Recent Company News
- 2026-05-27 20:05 EST — [AirSculpt Technologies Announces Participation in Upcoming Investor Conferences](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-announces-participation-in-upcoming-investor-conferences-2cfd961d) — Source: Airsculpt Technologies
- 2026-05-08 10:30 EST — [AirSculpt Technologies Reports First Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-reports-first-quarter-fiscal-2026-results-64ae47f1) — Source: Airsculpt Technologies
- 2026-05-01 10:45 EST — [AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-announces-earnings-release-date-conference-call-and-webca-d61b9662) — Source: Airsculpt Technologies
- 2026-04-06 10:30 EST — [CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results](https://biopharmsignal.com/news/AIRS/correction-airsculpt-technologies-reports-fourth-quarter-and-full-year-fiscal-20-805a94bd) — Source: Airsculpt Technologies
- 2026-04-02 10:30 EST — [AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results](https://biopharmsignal.com/news/AIRS/airsculpt-technologies-reports-fourth-quarter-and-full-year-fiscal-2025-results-7310ddce) — Source: Airsculpt Technologies
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)